ODSH + ICE Chemotherapy in Pediatric Solid Tumors

Summary

This study will be with pediatric patients who have refractory/recurrent solid tumors. They will receive standard chemotherapy (ICE) and we are investigating if the addition of a new drug, ODSH, will help to increase the time of their platelet recovery after ICE chemotherapy.The purpose of this study is to evaluate the safety and tolerability of ODSH in pediatric patients receiving "ICE" chemotherapy.

Timeline

Start

2015-01

Primary completion

2017-12

Completion

2017-12

Outcome

Outcome not reported

Stopped (Enrollment): “low accrual”

Drugs

Indications